Evidence map›Paper›PMID 38852572›Full record

ArticleInternational journal of surgery case reports2024

Proximal esophageal adenocarcinoma: A rare case report.

Atef Akoum, Jamil Nasrallah, Kholoud Al Jebawi, Nourhan Kanso, Hind Joumaa, Rana Ibrahim

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of surgery case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Atef AkoumInternal Medicine department, American University of Beirut, Lebanon.
Jamil NasrallahDepartment of Medicine, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon; Department of Life Sciences, Faculty of Sciences, Lebanese University, Beirut, Lebanon.
Kholoud Al JebawiDepartment of Medicine, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon; Department of Life Sciences, Faculty of Sciences, Lebanese University, Beirut, Lebanon.
Nourhan KansoDepartment of Medicine, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.
Hind JoumaaDepartment of Medicine and Surgery, Faculty of Medicine, Beirut Arab University, Beirut, Lebanon.
Rana IbrahimResearch Department at Saint George Hospital, Beirut, Lebanon. Electronic address: ranaibr94@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEsophageal cancer, notably rare in the proximal esophagus, demonstrates poor outcomes despite advanced treatments. This case underscores the successful management of proximal esophageal adenocarcinoma using chemoradiotherapy alone. CASE PRESENTATION: A 65-year-old Mediterranean woman presented with severe dysphagia and was diagnosed with stage IVA T4b N0M0 esophageal adenocarcinoma. She achieved complete remission after chemoradiotherapy, evidenced by PET CT scans, without surgical intervention. DISCUSSION: This case highlights the rarity of proximal esophageal adenocarcinoma and challenges the conventional treatment paradigm, emphasizing the potential of chemoradiotherapy as a standalone treatment in selected advanced cases.

conclusionThe complete response to chemoradiotherapy in this case of proximal esophageal adenocarcinoma illustrates the need for personalized treatment strategies and further research into non-surgical options for esophageal cancer management.

Indexed as

Adenocarcinoma cervical esophagusBarrett's esophagusCase reportEsophageal obstructionHeterotopic gastric mucosa

Identifiers

PMID38852572
PMCPMC11220545

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.